Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination Schedules

Clinical trial NCT00316147 · COMPLETED

Trial details

NCT number: NCT00316147
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Diphtheria Acellular Pertussis Tetanus Haemophilus Influenzae Type b Hepatitis B Poliomyelitis

Start date: 2005-12-01
Enrollment: 224

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.